AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) P/B ratio
As of 5 November 2026, AtriCure, Inc. (ATRC) trades at a P/B ratio of 5.6×. Over the past ten years it has ranged from 2.0× (June 2024) to 9.9× (July 2021); the current reading is higher than 80% of that period. That is above the Medical Instruments & Supplies industry median of 2.3× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 3.8× | 23.33% |
| FY2024 | 3.1× | (11.26%) |
| FY2023 | 3.5× | (21.86%) |
| FY2022 | 4.5× | (30.68%) |
| FY2021 | 6.5× | 13.91% |
| FY2020 | 5.7× | 15.10% |
| FY2019 | 4.9× | 18.12% |
| FY2018 | 4.2× | 12.69% |
| FY2017 | 3.7× | 3.01% |
| FY2016 | 3.6× | 6.83% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 5.2× | 95.44% |
| Jun 2026 | 2.6× | (5.98%) |
| Mar 2026 | 2.8× | (26.96%) |
| Dec 2025 | 3.8× | 8.32% |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| NVST Envista Holdings Corporation compare | 1.3× |
| MMED MiniMed Group, Inc. compare | 1.4× |
| XRAY DENTSPLY SIRONA Inc. compare | 1.5× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.0× |
| MMSI Merit Medical Systems, Inc. compare | 3.1× |
| ATRC AtriCure, Inc. | 5.6× |
| WRBY Warby Parker Inc. compare | 8.1× |
| PLSE Pulse Biosciences, Inc compare | 20.8× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement